Clinical Trials Directory

Trials / Conditions / Stage IVB Rectal Cancer AJCC v8

Stage IVB Rectal Cancer AJCC v8

11 registered clinical trials studyying Stage IVB Rectal Cancer AJCC v8 — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
NCT05038254
M.D. Anderson Cancer CenterN/A
Active Not RecruitingLY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastat
NCT04616183
M.D. Anderson Cancer CenterPhase 1 / Phase 2
Active Not RecruitingSX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the S
NCT04599140
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedRegorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metast
NCT04362839
City of Hope Medical CenterPhase 1
Active Not RecruitingPanitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type C
NCT03992456
Academic and Community Cancer Research UnitedPhase 2
TerminatedGenetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Tr
NCT03765736
Academic and Community Cancer Research United—
CompletedTAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Ca
NCT04109924
Roswell Park Cancer InstitutePhase 2
TerminatedSavolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641
National Cancer Institute (NCI)Phase 2
CompletedM7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instabil
NCT03436563
M.D. Anderson Cancer CenterPhase 1 / Phase 2
RecruitingEvaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
NCT02107105
M.D. Anderson Cancer Center—
Active Not RecruitingCirculating Tumor Cells in Patients With Locally Advanced Rectal Cancer
NCT02874885
M.D. Anderson Cancer Center—